Edition:
United Kingdom

Zeria Pharmaceutical Co Ltd (4559.T)

4559.T on Tokyo Stock Exchange

2,270JPY
18 Jan 2018
Change (% chg)

¥-24 (-1.05%)
Prev Close
¥2,294
Open
¥2,292
Day's High
¥2,298
Day's Low
¥2,265
Volume
153,600
Avg. Vol
108,637
52-wk High
¥2,348
52-wk Low
¥1,621

Latest Key Developments (Source: Significant Developments)

Zeria Pharmaceutical buys back 32,000 shares for 66.9 mln yen
Wednesday, 10 Jan 2018 

Jan 10 (Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it repurchased 32,000 shares for 66.9 million yen in total, from Dec. 1, 2017 to Dec. 31, 2017.Says this was part of the share repurchase plan announced on Nov. 2, 2017.Says it accumulatively repurchased 2.3 million shares for 4.73 billion yen in total, as of Dec. 31, 2017 .  Full Article

Zeria Pharmaceutical buys back 39,100 shares for 82.3 mln yen
Wednesday, 6 Dec 2017 

Dec 6(Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it bought back 39,100 shares for 82.3 million yen in total, from Nov. 1 to Nov. 30.Says this was part of the share repurchase plan revised on Nov. 2.  Full Article

Zeria Pharmaceutical says extension of share repurchase period
Thursday, 2 Nov 2017 

Nov 2(Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it extends share repurchase period to a deadline of Feb. 6, 2018, instead of Nov. 2 previously .Says share repurchase plan was announced on June 16 and revised on Aug. 4.  Full Article

Zeria Pharmaceutical to repurchase 6.8 pct shares
Friday, 4 Aug 2017 

Aug 4 (Reuters) - Zeria Pharmaceutical Co Ltd <4559.T>:Says it plans to repurchase up to 3.6 million shares, representing 6.8 percent of outstanding.Says share repurchase price at up to 7.2 billion yen in total.Says repurchase period from June 19 to Nov. 2.Previous news was disclosed on June 16.  Full Article

Zeria Pharmaceutical gets manufacture and marketing approval for Zentacort® Capsules 3mg
Wednesday, 28 Sep 2016 

Zeria Pharmaceutical Co Ltd <4559.T> :Says it gets manufacture and marketing approval for Zentacort® Capsules 3mg (Budesonide), as treatment for Crohn's disease.  Full Article

BRIEF-Zeria Pharmaceutical buys back 32,000 shares for 66.9 mln yen

* Says it repurchased 32,000 shares for 66.9 million yen in total, from Dec. 1, 2017 to Dec. 31, 2017